genet
polymorph
role
hcv
infecti
diseas
well
potenti
impact
clinic
diagnost
patient
stratif
therapi
final
broader
role
immunopathogenesi
noninfecti
inflammatori
diseas
consid
sinc
discoveri
type
iii
famili
found
contribut
significantli
host
respons
infect
whilst
share
mani
featur
type
ifn
induct
signal
pathway
tissuespecif
restrict
express
receptor
make
major
mediat
host
innat
immun
tissu
organ
high
epitheli
cell
content
host
suscept
respons
infect
known
heterogen
identif
common
genet
variant
link
diseas
outcom
genomewid
associ
studi
gwa
underscor
signific
host
polymorph
respons
infect
sever
gwa
highlight
locu
chromosom
area
genet
variat
significantli
associ
hepat
c
viru
hcv
infect
genotyp
use
clinic
practic
biomark
predict
success
respons
treatment
pegyl
ifn
ribavarin
discuss
pegyl
aa
african
american
c
caucasian
h
hispan
la
latin
american
eu
european
ch
chines
j
japanes
au
australian
italian
b
brazilian
na
north
american
african
swiss
origin
identifi
promot
host
respons
infect
complex
whilst
virul
infect
pathogen
play
major
role
establish
sever
diseas
contribut
host
genet
variat
diseas
suscept
outcom
infect
signific
sever
diseas
disord
known
caus
genet
variat
within
compon
immun
system
exampl
interferon
ifn
mediat
host
immun
pathway
genomewid
associ
studi
gwa
provid
power
tool
link
genet
polymorph
specif
diseas
enabl
identif
marker
associ
pathogen
includ
human
immunodefici
viru
hiv
hepat
c
viru
hcv
dengu
viru
malaria
mycobacterium
tuberculosi
three
independ
gwa
found
singlenucleotid
polymorph
snp
promot
region
significantli
associ
spontan
viru
clearanc
sustain
virolog
respons
svr
hcv
infect
follow
treatment
identif
snp
led
consider
effort
understand
locu
polymorph
influenc
hcv
infect
well
diseas
number
public
increas
around
almost
date
search
term
polymorph
review
provid
brief
overview
famili
numer
genet
polymorph
found
locu
relationship
variant
clinic
infect
medicin
import
ethnic
genet
consider
studi
diseas
associ
snp
discuss
final
explor
role
polymorph
noninfecti
diseas
highlight
widereach
implic
underli
genet
ifn
provid
first
line
innat
immun
defenc
virus
intracellular
bacteria
classifi
famili
base
upon
sequenc
homolog
receptor
specif
respons
initi
type
ifn
famili
subtyp
minor
ifn
bind
ubiquit
express
receptor
complex
induc
express
ifnstimul
gene
isg
via
heterodim
homodim
sole
type
ii
ifn
produc
larg
activ
cell
natur
killer
cell
bind
receptor
complex
induc
isg
via
homodim
type
iii
ifn
recent
discov
rel
new
addit
ifn
famili
bind
complex
ubiquit
receptor
less
common
receptor
induc
isg
via
type
iii
ifn
like
type
ifn
express
respons
viral
infect
despit
common
activ
antivir
signal
transduct
pathway
display
distinct
function
role
type
ifn
caus
rapid
peak
fall
isg
express
wherea
induc
steadi
increas
prolong
express
isg
due
part
induct
constitu
transactiv
subtyp
differenti
express
requir
addit
variat
isg
activ
subtyp
like
attribut
rel
level
subtyp
well
receptor
bind
affin
tissuespecif
express
transcript
activ
eg
repressor
eg
differ
ifn
express
receptor
utilis
subsequ
isg
induct
within
ifn
famili
suggest
like
complementari
role
host
defenc
invad
pathogen
famili
exert
antivir
activ
rang
rna
dna
virus
respons
divers
infect
includ
hepat
b
hbv
c
virus
hcv
herp
simplex
viru
type
cytomegaloviru
human
herpesviru
hiv
predomin
ifn
induc
respons
respiratori
virus
contribut
consider
control
viral
infect
respiratori
tract
includ
influenza
viru
human
metapneumoviru
sever
acut
respiratori
syndrom
sar
coronaviru
although
express
minor
individu
exert
antivir
activ
hcv
human
coronavirus
middl
east
respiratori
syndrom
mer
cov
despit
rel
low
level
express
capac
cell
respond
determin
express
receptor
subunit
predominantli
express
hepatocyt
cell
epitheli
origin
restrict
receptor
express
consequ
tissuespecif
antivir
effect
suggest
major
role
protect
epithelium
viral
infect
type
ifn
use
therapeut
treatment
cancer
due
overlap
downstream
signal
pathway
mount
evid
famili
share
antitumorigen
properti
demonstr
possess
proapoptot
antimetastat
effect
mous
model
well
human
lung
cancer
cell
line
vitro
find
highlight
signific
cellular
defenc
invad
viral
pathogen
malign
host
cell
gwa
aim
identifi
genet
determin
therapi
respons
hcv
patient
identifi
multipl
snp
within
locu
chromosom
link
diseas
treatment
outcom
sinc
numer
studi
verifi
associ
discov
correl
diseas
identifi
snp
within
locu
tabl
snp
locat
kb
upstream
fig
cc
genotyp
locat
associ
svr
pegyl
ribavirin
treatment
spontan
viral
clearanc
chronic
hcv
infect
similar
studi
found
haplotyp
polymorph
gcctag
overrepres
patient
fail
respond
treatment
particular
minor
g
allel
found
strongli
link
failur
clear
infect
null
virolog
respons
nvr
follow
identif
strong
predictor
therapi
outcom
hcv
patient
studi
cohort
found
altern
snp
better
predictor
treatment
success
strongest
predictor
diseas
outcom
japanes
popul
increas
number
ta
dinucleotid
peat
promot
region
also
strongli
link
success
viral
respons
japanes
individu
dinucleotid
variant
recent
identifi
frame
shift
allel
lead
express
major
variant
african
strongest
known
host
factor
predict
failur
clear
hcv
popul
homozyg
tt
genotyp
locu
also
strong
posit
correl
hcv
clearanc
treatment
outcom
linkag
disequilibrium
ld
snp
found
within
region
promin
featur
make
difficult
assign
caus
role
individu
snp
particularli
far
apart
sickl
cell
anaemia
exampl
function
snp
found
high
ld
snp
mbp
away
context
polymorph
high
ld
observ
r
give
latter
snp
limit
use
marker
popul
fig
howev
evid
genotyp
actual
provid
better
predict
therapi
outcom
caucasian
coinfect
hcv
highlight
difficulti
form
reliabl
associ
diseas
snp
abil
cell
respond
depend
express
receptor
evid
snp
gene
link
chronic
hcv
infect
whilst
major
allel
aa
found
overrepres
persist
infect
albeit
untreat
atrisk
group
chines
popul
minor
g
allel
link
treatment
failur
chronic
hcv
cui
et
al
also
found
gg
allel
link
reduc
suscept
persist
hcv
howev
later
studi
chines
han
popul
found
link
investig
much
larger
sampl
group
requir
fulli
understand
role
polymorph
diseas
whilst
impact
snp
hcv
clear
role
hbv
infect
remain
controversi
despit
increas
global
interest
review
sever
snp
studi
hbv
patient
cohort
cg
haplotyp
block
found
associ
hbv
seroclear
posit
link
respons
pegyl
therapi
addit
snp
low
ld
link
chronic
hepat
hbeagneg
patient
p
howev
mani
report
found
link
chronic
hbv
infect
consensu
role
yet
reach
area
hcv
signific
associ
made
snp
locu
diseas
suscept
treatment
outcom
howev
mechan
via
polymorph
function
influenc
innat
immun
remain
ill
defin
numer
snp
within
locu
fig
mani
locat
promot
region
could
directli
influenc
protein
express
alter
transcript
factor
bind
affin
chromatin
access
exampl
snp
propos
locat
within
cpg
island
methyl
deamin
cpg
island
caus
epigenet
chang
promot
recruit
protein
associ
less
transcript
activ
heterochromat
dna
thu
may
alter
express
whilst
recent
investig
transcript
regul
suggest
major
control
occur
within
first
kilo
base
pair
upstream
exclud
well
establish
risk
allel
snp
g
respect
alter
mrna
protein
express
peripher
blood
mononuclear
cell
sera
liver
hcv
patient
well
healthi
individu
addit
locat
within
cpg
island
allel
associ
express
reduc
express
mrna
high
ld
snp
combin
physiolog
effect
reduc
increas
express
associ
feedback
mechan
remain
unclear
promot
polymorph
consist
ta
nucleotid
repeat
whilst
evid
suggest
increas
length
ta
repeat
result
higher
level
transcript
activ
mechan
undefin
recent
host
polymorphismdepend
express
link
hcvinduc
microrna
mirna
highli
express
liver
high
level
link
protect
cc
genotyp
svr
chronic
although
increas
hcv
rna
replic
vitro
correl
found
high
reduc
hcv
viral
load
liver
favour
g
allel
second
polymorph
untransl
region
utr
found
resist
posttranscript
regul
aurich
elementmedi
decay
via
hcvinduc
studi
provid
entic
evid
interplay
host
regulatori
element
genet
polymorph
diseas
control
follow
origin
gwa
studi
numer
subsequ
independ
revalid
patient
genotyp
known
associ
likelihood
achiev
svr
pegyl
ifn
ribavarin
therapi
current
guidelin
recommend
genotyp
test
result
would
influenc
manag
plan
consid
substanti
side
effect
burden
ifn
therapi
patient
may
reluct
start
treatment
knowledg
genotyp
like
respons
treatment
facilit
inform
decis
howev
truli
remark
efficaci
new
directact
antivir
agent
treatment
genotyp
hcv
infect
mean
pegyl
ifn
ribavarin
therapi
regim
obsolet
remain
seen
whether
genotyp
also
predict
respons
new
directact
antivir
agent
addit
role
hcv
infect
snp
investig
context
infecti
diseas
follow
identif
antivir
host
factor
infect
vitro
genotyp
explor
patient
suffer
recurr
orofaci
herp
minor
allel
found
associ
sever
frequenc
oral
herp
labiali
recurr
recent
studi
hivinfect
patient
found
individu
homozyg
mutat
snp
higher
incid
develop
cmv
retin
infect
retin
epitheli
cell
cmv
caus
retin
damag
result
blind
reduc
express
result
mutat
may
contribut
higher
replic
level
cmv
increas
likelihood
develop
retin
snp
also
investig
context
hiv
control
suppress
hiv
viral
load
absenc
therapi
one
studi
found
protect
cc
genotyp
associ
spontan
hiv
control
howev
addit
low
number
comparison
noncontrol
vs
group
also
high
rate
hcv
coinfect
make
firm
conclus
difficult
genet
variat
also
link
infect
potenti
oncogen
virus
human
papilloma
viru
human
tlymphotrop
leukaemia
viru
htlv
type
genet
associ
studi
found
snp
link
human
papilloma
viru
persist
cervic
cancer
albeit
low
signific
risk
allel
ct
gg
link
incid
myelopathytrop
spastic
paraparesi
howev
anoth
studi
fail
link
genotyp
diseas
even
though
protect
allel
tt
associ
higher
level
monoinfect
patient
comparison
coinfect
patient
viru
predominantli
infect
tlymphocyt
relev
polymorph
gener
type
iii
ifn
respons
infect
associ
inflammatori
diseas
clear
studi
larger
cohort
requir
fulli
understand
role
develop
virusinduc
cancer
despit
major
ifn
express
airway
cell
respons
infect
surprisingli
littl
known
effect
snp
respiratori
infecti
diseas
one
studi
explor
snp
infant
hospitalis
rsvassoci
bronchiol
found
link
cours
clinic
infect
viral
load
even
though
signific
associ
rais
level
airway
secret
sever
diseas
infant
hospitalis
due
rsv
bronchiol
observ
appar
neg
link
diseas
prognosi
rais
possibl
overexpress
may
actual
detriment
patient
health
particularli
context
respiratori
infect
infect
predomin
induct
may
contribut
significantli
phenomenon
hypercytokinaemia
acut
respiratori
distress
syndrom
respiratori
failur
necessit
mechan
ventil
lifethreaten
diseas
suppress
allerg
asthma
mous
model
result
promot
suppress
respons
bronchial
epitheli
cell
asthmat
patient
impair
abil
express
respons
infect
possibl
therefor
polymorph
reduc
level
respons
domin
cell
result
inflammatori
allerg
diseas
one
studi
found
risk
allel
overrepres
cohort
allergi
suffer
howev
contradictori
report
elev
level
asthma
patient
indic
need
studi
elucid
role
polymorph
inflammatori
diseas
express
signal
also
link
autoimmun
diseas
system
lupu
erythematosu
sle
higher
level
mrna
protein
subsequ
stimul
cytokin
express
sle
patient
thought
contribut
observ
inflamm
associ
organ
damag
sle
diseas
interestingli
snp
minor
allel
link
increas
risk
sle
chines
han
popul
whilst
effect
polymorph
known
locat
utr
suggest
may
influenc
receptor
express
whilst
underli
caus
sle
remain
undefin
infecti
agent
long
suspect
review
unsurpris
therefor
find
link
host
polymorph
influenc
pathway
sle
role
inflammatori
autoimmun
diseas
warrant
investig
studi
snp
locu
show
extens
geograph
variat
allel
frequenc
c
allel
associ
clearanc
hcv
present
high
rate
eastasian
popul
low
rate
african
popul
fig
dispar
c
allel
frequenc
correl
observ
clinic
differ
popul
east
asian
time
greater
rate
hcv
clearanc
ethnicitydepend
distribut
protect
cc
genotyp
also
partial
explain
differ
svr
african
american
european
american
chronic
infect
occur
often
peopl
african
descent
compar
caucasian
popul
variat
allel
frequenc
v
e
r
g
e
c
u
c
n
n
also
like
contribut
global
variat
predictor
genotyp
snp
strongest
predictor
hcv
therapi
outcom
japanes
african
popul
respect
intraregion
variat
snp
allel
frequenc
also
note
cc
frequenc
rang
asian
australian
mediterranean
australian
fig
high
level
variat
even
within
rel
small
popul
australian
million
consid
utilis
genotyp
patient
stratif
observ
correl
geograph
distinct
genotyp
chronic
diseas
preval
provid
evolutionari
evid
mainten
protect
allel
snp
ie
mainten
cc
area
endem
chronic
hcv
howev
explain
high
preval
socal
risk
allel
snp
popul
australian
aborigin
mediterranean
popul
wellknown
genet
disord
sickl
cell
anaemia
individu
homozyg
mutat
question
suffer
sever
diseas
whilst
heterozygos
actual
confer
level
protect
malaria
possibl
therefor
risk
allel
may
confer
yet
unidentifi
genet
advantag
popul
whilst
simultan
render
other
suscept
chronic
diseas
hcv
interestingli
also
evid
gender
bia
respect
associ
snp
hcv
genotyp
found
reliabl
predictor
favour
outcom
hcv
infect
femal
gender
gender
bia
support
later
studi
show
similar
rate
spontan
viral
clearanc
women
ttct
allel
men
favour
cc
genotyp
gender
bia
also
observ
allerg
diseas
studi
snp
found
femal
children
protect
cc
genotyp
decreas
rate
allergyassoci
epidermi
symptom
sinc
discoveri
explos
data
describ
possibl
role
type
iii
ifn
infecti
noninfecti
human
diseas
whilst
assess
host
genet
contribut
diagnost
therapi
option
oncolog
surprisingli
underexploit
field
medicin
polymorph
host
snp
use
genet
biomark
infecti
diseas
genotyp
locu
incorpor
patient
stratif
clinic
manag
hcv
infect
whilst
link
polymorph
hcv
infect
robust
well
describ
review
highlight
number
infecti
inflammatori
diseas
polymorph
affect
express
signal
implic
data
mani
diseas
howev
remain
unconvinc
mani
studi
limit
often
small
sampl
size
small
effect
size
variat
patient
characterist
make
interstudi
comparison
difficult
given
level
intraregion
genotyp
variat
within
popul
caution
use
interpret
popul
stratif
associ
studi
particularli
rel
high
p
valu
final
exist
ld
snp
within
locu
make
difficult
assign
causal
individu
polymorph
howev
seem
like
host
polymorph
affect
signal
axi
play
key
role
advanc
field
novel
host
biomark
patient
manag
differenti
therapi
